The emergence of CRISPR ethics has sparked a vital conversation in the realm of gene editing, particularly concerning its implications for health equity and bioethics.As scientists unlock the potential to modify genetic material, the ability to cure diseases like sickle cell anemia raises significant moral dilemmas.